Company Filing History:
Years Active: 2003-2011
Title: Walter Boudewijin Leopold Wouters: Innovator in Pharmaceutical Science
Introduction
Walter Boudewijin Leopold Wouters is a notable inventor based in Kapellen, Belgium. He has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative compounds for cancer treatment. With a total of 2 patents, Wouters has demonstrated his commitment to advancing medical research and improving patient outcomes.
Latest Patents
Wouters' latest patents include "Substituted 2-alkyl quinazolinone derivatives as PARP inhibitors." This invention provides compounds of formula (I) and their use as PARP inhibitors, along with pharmaceutical compositions containing these compounds. The defined meanings of R, R, L, X, Y, and Z are crucial for understanding the application of these compounds in medical treatments. Another significant patent is "Farnesyl Protein transferase inhibitors with in vivo radiosensitizing properties." This invention highlights the discovery that farnesyl protein transferase inhibitors possess radiosensitizing properties, making them valuable for preparing pharmaceutical compositions for administration before, during, or after tumor irradiation in cancer treatment.
Career Highlights
Wouters is currently associated with Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. His work focuses on developing innovative solutions that address critical health challenges. His expertise in the field has positioned him as a key player in pharmaceutical research and development.
Collaborations
Wouters has collaborated with esteemed colleagues, including Robert Franciscus Van Ginckel and Wim Joanna Floren. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries in the pharmaceutical sector.
Conclusion
Walter Boudewijin Leopold Wouters is a distinguished inventor whose work in pharmaceutical science has the potential to transform cancer treatment. His innovative patents and collaborations reflect his dedication to improving healthcare through scientific advancements.